TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/15/23 16:04 | 8/11/23 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Smith Cynthia | MA | D | M.d | 0 | 0.00 | 0 | 2 | New | 2 | D | |||||||||||||||
6/7/21 21:35 | 6/3/21 | DRNA | Dicerna Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Cynthia | MA | D | M.d | 0 | 0.00 | 0 | 3 | New | 3 | D | |||||||||||||||
6/9/20 16:17 | 6/8/20 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Smith Cynthia | MA | D | S.d | -55 | 12.10 | 0 | -5 | -11 | 38 | D | |||||||||||||||
11/22/19 06:20 | 11/20/19 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Smith Cynthia | MA | D | P | 53 | 3.52 | 0 | 15 | 109 | 29 | D | |||||||||||||||
12/10/15 21:23 | 12/8/15 | ZSPH | Zs Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Smith Cynthia | CA | O | Chief Co | M.d | 100 | 10.92 | 33 | 9 | New | 9 | D | 90 | 53 | 20 | 36 | 0 | 0 | 0 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |